Pharmaceutical

AI in Regulatory Medical Writing: Balancing Innovation with Human Expertise, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how AI can support, rather than replace, the essential expertise of medical writing teams. Attendees…

4 months ago

CLS Health’s Back-to-School Campaign Provides Families With All Their Medical Needs in One Convenient Place

With 45-plus locations and more than 225 providers, the physician-owned practice makes it simpler for families to get all the…

4 months ago

$12.9M Dual Logoman Auto Sale Highlights MDCE (OTC PINK:MDCE) Subsidiary Infinite Auctions’ Move Into Tom Brady 1/1 NFL Logo Auto

Acquisition underscores Infinite Auctions' momentum as 1-of-1 cards of sports legends reach record-breaking values MESA, ARIZONA / ACCESS Newswire /…

4 months ago

Healthcare Providers Ill-Prepared for Looming September 2025 Telehealth Policy Cliff

Black Book Research survey reveals compliance gaps, weak technology readiness, and mounting patient care risks as Medicare telehealth flexibilities approach…

4 months ago

Rusfertide Receives Breakthrough Therapy Designation for Treatment of Erythrocytosis in Patients with Polycythemia Vera

Breakthrough Therapy designation complements Rusfertide's Orphan Drug and Fast Track designations, which together confer multiple benefits to the development programU.S.…

4 months ago

Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108

– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan  –…

4 months ago

24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets

Current Clinical Trial Focus is MSS Colorectal Cancer, Ovarian Clear-Cell Carcinoma, and Soft-Tissue SarcomaDENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) --…

4 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug.…

4 months ago

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

Company’s pembrolizumab-based immune checkpoint inhibitor exhibited success against solid tumors in IND-enabling studies by simultaneously activating immune cells and promoting their…

4 months ago